In vitro effects of omeprazole in combination with antifungal compounds against Malassezia pachydermatis [PDF]
Veterinary Medicine and Science, 2023 Background Fungal and yeast infections, including those caused by Malassezia spp., are becoming increasingly difficult to treat, likely due to the occurrence of drug resistance. Objectives This study aimed to evaluate the antifungal effects of omeprazole
Juyoung Shin, Seulgi Bae
doaj +3 more sources
Invasive Malassezia pachydermatis Infection in an 8-Year-Old Child on Lipid Parenteral Nutrition [PDF]
Case Reports in Infectious Diseases, 2022 Invasive disease due to Malassezia pachydermatis infection is uncommon but increasingly recognized in children, especially neonates on parenteral nutrition or immunocompromised children.
Zheyi Teoh +2 more
doaj +3 more sources
In vitro antifungal activity of cold atmospheric microwave plasma and synergistic activity against Malassezia pachydermatis when combined with chlorhexidine gluconate [PDF]
Veterinary Medicine and Science, 2022 Background The antifungal efficacy of cold atmospheric microwave plasma (CAMP) against Malassezia pachydermatis has not been to be evaluated. Objective To examine the antifungal effects of CAMP against M.
Tae‐Hyun Lee +4 more
doaj +3 more sources
In Vitro Biofilm Formation by Malassezia pachydermatis Isolates and Its Susceptibility to Azole Antifungals [PDF]
Journal of Fungi, 2022 The yeast Malassezia pachydermatis, an opportunistic pathogen that inhabits the skin of various domestic and wild animals, is capable of producing a biofilm that plays an important role in antifungal resistance. The aim of this research study was to find
Eva Čonková +3 more
doaj +3 more sources
Prevalence of Malassezia pachydermatis yeasts in clinical infections in dogs: A single-center retrospective study at the University Veterinary Hospital, Stara Zagora, Bulgaria (2019–2023) [PDF]
Open Veterinary JournalBackground: Malassezia yeasts are part of the resident microbiota of canine skin and ear canal. The compromised immunity of animals, changes in environmental factors, and antibacterial treatment often result in their proliferation and subsequent ...
Velina Dinkova, Nikolina Rusenova
doaj +3 more sources
Mechanism of the synergistic action of oxythiamine and ketoconazole against the yeast Malassezia pachydermatis. [PDF]
FEMS Yeast ResThis article explains the biochemical basis of the synergistic effect of oxythiamine (OT) and ketoconazole (KTC) against Malassezia pachydermatis yeast, which was isolated from dogs exhibiting clinical signs of otitis externa.
Czerniecka M, Więcko A, Tylicki A.
europepmc +2 more sources
Antifungal Susceptibility of <i>Malassezia pachydermatis</i> Isolates from Companion Animals and Genomic Insights into Resistance Mechanisms. [PDF]
Antibiotics (Basel)Background/Objectives: Malassezia pachydermatis is a lipophilic yeast frequently associated with otitis externa and dermatological disorders in companion animals. This study aimed to evaluate the antifungal susceptibility of M.
Domán M +5 more
europepmc +2 more sources
Antifungal Efficacy of Selected Plant Essential Oils Against Clinical Canine Isolates <i>Malassezia pachydermatis</i>. [PDF]
MicroorganismsMalassezia pachydermatis, an important opportunistic secondary pathogen, is often associated with atopic dermatitis or otitis externa in dogs. Recent studies indicate an increase in resistance of this yeast to commonly used antifungal agents.
Čonková E, Váczi P, Malinovská Z.
europepmc +2 more sources
Comparative efficacy of selenoureido carbonic anhydrase inhibitors and azole antifungal drugs against clinical isolates of Malassezia pachydermatis. [PDF]
Vet DermatolBackground Malassezia pachydermatis (MP) is implicated in severe dermatitis and otitis externa (OE) of companion animals and recently gained attention for its increasing resistance to azole compounds.
Spadini C +11 more
europepmc +2 more sources
Azole and terbinafine susceptibility testing of Malassezia pachydermatis in Japan. [PDF]
J Vet Med Sci, 2023 Canine Malassezia dermatitis and otitis externa are generally treated by antifungal drugs. However, multi-drug-resistant strains of Malassezia pachydermatis have been reported worldwide.
Murayama N, Kano R.
europepmc +2 more sources